• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What Harm Are We Doing to Our Patients with Asthma by Using High-Dose Inhaled Corticosteroids?

作者信息

Sin Don D, Busse William W

机构信息

University of Alberta, Medicine, Edmonton, Canada;

University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, United States.

出版信息

Am J Respir Crit Care Med. 2024 Sep 3;211(1):4-6. doi: 10.1164/rccm.202407-1428ED.

DOI:10.1164/rccm.202407-1428ED
PMID:39226124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11755353/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/11755353/c51c59c75abc/rccm.202407-1428EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/11755353/c51c59c75abc/rccm.202407-1428EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f83/11755353/c51c59c75abc/rccm.202407-1428EDf1.jpg

相似文献

1
What Harm Are We Doing to Our Patients with Asthma by Using High-Dose Inhaled Corticosteroids?使用高剂量吸入性糖皮质激素对哮喘患者有何危害？
Am J Respir Crit Care Med. 2024 Sep 3;211(1):4-6. doi: 10.1164/rccm.202407-1428ED.
2
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.福莫特罗与吸入性类固醇联合长期治疗慢性哮喘：严重不良事件
Cochrane Database Syst Rev. 2009 Apr 15(2):CD006924. doi: 10.1002/14651858.CD006924.pub2.
3
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.慢性哮喘患者使用福莫特罗和吸入性类固醇进行常规治疗：严重不良事件
Cochrane Database Syst Rev. 2013 Jun 7(6):CD006924. doi: 10.1002/14651858.CD006924.pub3.
4
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.在患有持续性哮喘的成人和儿童中，长效β2受体激动剂与高剂量吸入性类固醇联合使用与单纯使用高剂量吸入性类固醇的比较。
Cochrane Database Syst Rev. 2010 Apr 14(4):CD005533. doi: 10.1002/14651858.CD005533.pub2.
5
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.吸入长效β2受体激动剂与吸入性糖皮质激素联合使用与高剂量吸入性糖皮质激素治疗儿童和成人持续性哮喘的比较
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005533. doi: 10.1002/14651858.CD005533.
6
Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.福莫特罗与布地奈德联合用于成人和儿童慢性哮喘的维持和缓解治疗与当前最佳实践（包括吸入性糖皮质激素维持治疗）的对比研究
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD007313. doi: 10.1002/14651858.CD007313.pub3.
7
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.对于未使用过类固醇的成人和儿童持续性哮喘，吸入长效β2受体激动剂联合吸入性类固醇作为一线治疗方案。
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD005307. doi: 10.1002/14651858.CD005307.pub2.
8
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.沙美特罗与吸入性糖皮质激素联合常规治疗慢性哮喘：严重不良事件
Cochrane Database Syst Rev. 2009 Jul 8(3):CD006922. doi: 10.1002/14651858.CD006922.pub2.
9
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.在复发性和/或慢性哮喘管理中，抗白三烯药物与吸入性糖皮质激素的比较。
Cochrane Database Syst Rev. 2000(3):CD002314. doi: 10.1002/14651858.CD002314.
10
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.在成人和儿童复发性和/或慢性哮喘管理中，抗白三烯药物与吸入性糖皮质激素的比较
Cochrane Database Syst Rev. 2004(2):CD002314. doi: 10.1002/14651858.CD002314.pub2.

本文引用的文献

1
Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events.吸入性糖皮质激素剂量与不良事件发生频率的关联
Am J Respir Crit Care Med. 2024 Aug 1;211(1):54-63. doi: 10.1164/rccm.202402-0368OC.
2
Association between the cumulative dose of glucocorticoids before the development of pneumonia and death in patients receiving long-term glucocorticoids: a secondary analysis based on a Chinese cohort study.长期接受糖皮质激素治疗的患者在发生肺炎前糖皮质激素累积剂量与死亡之间的关联：基于一项中国队列研究的二次分析
Front Med (Lausanne). 2023 Jul 20;10:1175855. doi: 10.3389/fmed.2023.1175855. eCollection 2023.
3
Biologic Therapies for Severe Asthma.
重度哮喘的生物疗法
N Engl J Med. 2022 Jan 13;386(2):157-171. doi: 10.1056/NEJMra2032506.
4
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.全球哮喘倡议 2021 策略：执行摘要和关键变更的理由。
Am J Respir Crit Care Med. 2022 Jan 1;205(1):17-35. doi: 10.1164/rccm.202109-2205PP.
5
Effects of Inhaled Corticosteroid/Long-Acting β-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM).吸入性皮质类固醇/长效β激动剂联合治疗对慢性阻塞性肺疾病患者气道微生物组的影响：一项随机对照临床试验（DISARM）。
Am J Respir Crit Care Med. 2021 Nov 15;204(10):1143-1152. doi: 10.1164/rccm.202102-0289OC.
6
Neutrophils in asthma: the good, the bad and the bacteria.哮喘中的中性粒细胞：有益、有害与细菌
Thorax. 2021 Feb 25;76(8):835-44. doi: 10.1136/thoraxjnl-2020-215986.
7
12-year adherence to inhaled corticosteroids in adult-onset asthma.成人哮喘患者吸入糖皮质激素的12年依从性
ERJ Open Res. 2020 Mar 23;6(1). doi: 10.1183/23120541.00324-2019. eCollection 2020 Jan.
8
Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology.成人哮喘吸入性皮质类固醇治疗。是时候采用新的治疗剂量术语了。
Am J Respir Crit Care Med. 2019 Jun 15;199(12):1471-1477. doi: 10.1164/rccm.201810-1868CI.
9
Inhaled corticosteroids for chronic obstructive pulmonary disease.吸入性糖皮质激素用于慢性阻塞性肺疾病
BMJ. 2012 Oct 25;345:e6843. doi: 10.1136/bmj.e6843.
10
Effect of inhaled glucocorticoids in childhood on adult height.吸入性糖皮质激素对儿童成年身高的影响。
N Engl J Med. 2012 Sep 6;367(10):904-12. doi: 10.1056/NEJMoa1203229. Epub 2012 Sep 3.